You are here

  • Home
  • Archive
  • Volume 8, Issue Suppl 10
  • PA-276 Differences in risk factors between a high and low vertical HIV transmission setting: implications for elimination of new paediatric HIV infections

Article Text

Article menu

Download PDFPDF

Abstracts of Poster and e-Poster Presentations
PA-276 Differences in risk factors between a high and low vertical HIV transmission setting: implications for elimination of new paediatric HIV infections
Free
  1. Issa Sabi1,
  2. Kira Elsbernd2,3,
  3. Bindiya Meggi4,
  4. Anange Fred Lwilla1,
  5. Nyanda Elias Ntinginya1,
  6. Kassia Pereira4,
  7. Arlete Mahumane4,
  8. Siriel Boniface1,
  9. Raphael Edom1,
  10. Joaquim Lequechane4,
  11. Falume Chale4,
  12. Chishamiso Mudenyanga5,
  13. Dadirayi Mutsaka5,
  14. Mariana Mueller2,
  15. W Chris Buck6,
  16. Michael Hoelscher2,7,8,
  17. Ilesh Jani4,
  18. Arne Kroidl2,7,
  19. the LIFE Study Consortium
  1. 1Mbeya Medical Research Center, National Institute For Medical Research, United Republic of Tanzania
  2. 2Division of Infectious Diseases and Tropical Medicine, University Hospital, LMU Munich, Germany
  3. 3Institute for Medical Information Processing, Biometry, and Epidemiology, University Hospital, LMU Munich, Germany
  4. 4Instituto Nacional de Saúde (INS), Mozambique
  5. 5Clinton Health Access Initiative (CHAI), Mozambique
  6. 6University of California Los Angeles, David Geffen School of Medicine, USA
  7. 7German Center for Infection Research (DZIF), partner site Munich, Germany
  8. 8Fraunhofer ITMP, Immunology, Infection and Pandemic Research, Germany

Abstract

Background Roughly 1.3 million infants are exposed and 150,000 newly diagnosed with Human Immunodeficiency Virus (HIV) annually. Estimates of Vertical HIV transmission (VHT) rates vary by setting. In this study, we assessed the risk factors for VHT among infants born to women living with HIV in Tanzania and Mozambique.

Methods Between October 2019 and August 2021, data was collected from pregnant women living with HIV who participated in the LIFE study [RIA2016MC] at 28 obstetric health facilities in Tanzania and Mozambique. VHT was assessed up to month 3 of age in all infants. At baseline, demographics and clinical characteristics were collected to assess risk factors for VHT. Mixed effects models adjusted for health facility clustering were used to calculate risk ratios.

Results In total, 6,509 women living with HIV and their 6,605 exposed infants were included in the study. VHT up to month 3 of life was 2.69% (95% CI: 2.21, 3.24) in Mozambique, significantly higher than the 0.62% (95% CI: 0.35, 1.00) observed in Tanzania (RR: 4.45, 95% CI: 2.63, 7.99). On average, Tanzanian women were significantly older, attended antenatal care more frequently, and had been on antiretroviral treatment for a longer period. After adjusting for these factors, virologic non-suppression at delivery was the principal risk factor for transmission (RR: 35.7, 95% CI: 19.2, 73.1). In Mozambique, 31.0% of all mothers were not suppressed at delivery compared to 8.1% in Tanzania; only 8.9% (11/124) infants who acquired HIV by month 3 had mothers who were virally suppressed at delivery.

Conclusion We observed a striking difference in VHT between countries. Lack of viral suppression at delivery was the main risk factor for VHT, highlighting the need for better understanding the individual, community, and health system factors associated with lack of viral suppression in pregnant and lactating women living with HIV.

https://doi.org/10.1136/bmjgh-2023-EDC.138

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.